View Item 

Show simple item record

Editorial: histologic normalisation in ulcerative colitis. Authors’ reply

dc.contributor.authorCushing, Kelly C.
dc.contributor.authorAnanthakrishnan, Ashwin N.
dc.date.accessioned2020-02-05T15:08:14Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-02-05T15:08:14Z
dc.date.issued2020-02
dc.identifier.citationCushing, Kelly C.; Ananthakrishnan, Ashwin N. (2020). "Editorial: histologic normalisation in ulcerative colitis. Authors’ reply." Alimentary Pharmacology & Therapeutics 51(3): 401-401.
dc.identifier.issn0269-2813
dc.identifier.issn1365-2036
dc.identifier.urihttps://hdl.handle.net/2027.42/153729
dc.publisherWiley Periodicals, Inc.
dc.titleEditorial: histologic normalisation in ulcerative colitis. Authors’ reply
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153729/1/apt15621.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153729/2/apt15621_am.pdf
dc.identifier.doi10.1111/apt.15621
dc.identifier.sourceAlimentary Pharmacology & Therapeutics
dc.identifier.citedreferencePai RK, Jairath V, Feagan B. Editorial: histologic normalisation in ulcerative colitis. Aliment Pharmacol Ther 2020, in press.
dc.identifier.citedreferenceBarreiro‐de Acosta M, Vallejo N, de la Iglesia D, et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): a longitudinal cohort study. J Crohns Colitis. 2016; 10: 13 ‐ 19.
dc.identifier.citedreferencePeyrin‐Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat‐to‐target. Am J Gastroenterol. 2015; 110: 1324 ‐ 1338.
dc.identifier.citedreferencePeyrin‐Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol. 2014; 12: 929 ‐ 934.e2.
dc.identifier.citedreferenceIsrael A, Christensen B, El Jurdi K, et al. Follow‐up of ulcerative colitis patients who have achieved histological normalization. Clin Gastroenterol Hepatol. 2019; S1542-3565(19)30663-9.
dc.identifier.citedreferenceChristensen B, Hanauer SB, Erlich J, et al. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol. 2017; 15: 1557 ‐ 1564.e1.
dc.identifier.citedreferenceCushing KC, Tan W, Alpers DH, Deshpande V, Ananthakrishnan AN. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission. Aliment Pharmacol Ther. 2019; 1 ‐ 9. https://doi.org/10.1111/apt.15568.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
apt15621.pdf
Size:
197.2KB
Format:
PDF
View/Open
Name:
apt15621_am.pdf
Size:
103.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.